(Q42908666)

10 November 2017

A chronic dose-ranging study of the pharmacokinetics of phenylbutazone in rheumatoid arthritic patients (English)

1 reference

10 November 2017

A chronic dose‐ranging study of the pharmacokinetics of phenylbutazone in rheumatoid arthritic patients (English)

1 reference

https://api.crossref.org/works/10.1111/J.1365-2125.1981.TB01190.X

26 April 2024

author name string

C. Higham

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7306426

26 April 2024

L. Aarons

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7306426

26 April 2024

P. J. Holt

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7306426

26 April 2024

M. Lynch

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7306426

26 April 2024

M. Rowland

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7306426

26 April 2024

language of work or name

English

0 references

publication date

1 August 1981

1 reference

full work available at URL

10 November 2017

https://europepmc.org/articles/pmc1401862?pdf=render

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7306426

https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/7306426/pdf/?tool=EBI

26 April 2024

file format

Portable Document Format

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7306426

https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/7306426/?tool=EBI

26 April 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7306426

https://europepmc.org/articles/PMC1401862

26 April 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7306426

https://europepmc.org/articles/PMC1401862?pdf=render

26 April 2024

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7306426

http://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2125.1981.tb01190.x

26 April 2024

1 reference

https://api.crossref.org/works/10.1111/J.1365-2125.1981.TB01190.X

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2125.1981.tb01190.x

26 April 2024

1 reference

https://api.crossref.org/works/10.1111/J.1365-2125.1981.TB01190.X

https://bpspubs.onlinelibrary.wiley.com/doi/pdf/10.1111/j.1365-2125.1981.tb01190.x

26 April 2024

1 reference

https://api.crossref.org/works/10.1111/J.1365-2125.1981.TB01190.X

British Journal of Clinical Pharmacology

26 April 2024

published in

1 reference

10 November 2017

12

1 reference

10 November 2017

2

1 reference

10 November 2017

123-129

1 reference

Plasma concentration of phenylbutazone and its therapeutic effect-studies in patients with rheumatoid arthritis

10 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1401862

The serum level approach to individualization of drug dosage

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1401862

Phenylbutazone: a clinico-pharmacological study in rheumatoid arthritis

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1401862

Clinical Pharmacokinetics of Phenylbutazone

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1401862

The physiological disposition of phenylbutazone (butazolidin) in man and a method for its estimation in biological material.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1401862

Genetic control of drug levels in man: phenylbutazone

16 August 2018

1 reference

12 December 2020

Individual Differences in the Plasma Half-lives of Lipid Soluble Drugs in Man

1 reference

12 December 2020

Disposition and oxidative metabolism of phenylbutazone in man

1 reference

12 December 2020

A STUDY OF STRUCTURE--ACTIVITY RELATIONSHIPS IN REGARD TO SPECIES DIFFERENCE IN THE PHENYLBUTAZONE SERIES

1 reference

12 December 2020

An improved HPLC assay for monitoring phenylbutazone and its two major oxidised metabolites in plasma

1 reference

12 December 2020

Phenylbutazone therapy; relation between the toxic and therapeutic effects and the blood level

1 reference

12 December 2020

Phenylbutazone metabolites: antirheumatic, sodium-retaining and uricosuric effects in man

1 reference

12 December 2020

Bioavailability evaluation of an enteric-coated phenylbutazone formulation, and cross-over comparison with a sugar-coated product

1 reference

12 December 2020

Identifiers

1 reference

10 November 2017

1 reference

10 November 2017

1 reference